Weiser R - Search Results

1

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.

Ho J, Mattei J, Tetzlaff M, Williams MD, Davies MA, Diab A, Oliva ICG, McQuade J, Patel SP, Tawbi H, Wong MK, Fisher SB, Hanna E, Keung EZ, Ross M, Weiser R, Su SY, Frumovitz M, Meyer LA, Jazaeri A, Pettaway CA, Guadagnolo BA, Bishop AJ, Mitra D, Farooqi A, Bassett R, Faria S, Nagarajan P, Amaria RN. Ho J, et al. Among authors: weiser r. Front Oncol. 2022 Oct 17;12:1001150. doi: 10.3389/fonc.2022.1001150. eCollection 2022. Front Oncol. 2022. PMID: 36324592 Free PMC article.

2

De-escalation of Post-mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes.

Halfteck GG, Polychronopoulou YE, Haque W, Weiser R, Hatch SS, Klimberg VS. Halfteck GG, et al. Among authors: weiser r. Ann Surg Oncol. 2023 Dec;30(13):8335-8343. doi: 10.1245/s10434-023-14155-2. Epub 2023 Sep 7. Ann Surg Oncol. 2023. PMID: 37679538

3

Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases: An NCDB Analysis.

Weiser R, Polychronopoulou E, Haque W, Hatch SS, He J, Qiu S, Markowitz A, Gradishar WJ, Kuo YF, Klimberg VS. Weiser R, et al. Ann Surg Oncol. 2021 Dec;28(13):8717-8727. doi: 10.1245/s10434-021-10374-7. Epub 2021 Jul 11. Ann Surg Oncol. 2021. PMID: 34250555

4

[No title available]

[No authors listed] [No authors listed] PMID: 34260008

5

Fluoroscopic Intraoperative Breast Neoplasm and Node Detection.

Weiser R, Manno GC, Cass SH, Chen L, Kuo YF, He J, Robinson AS, Posleman Monetto F, Silva HC, Klimberg VS. Weiser R, et al. J Am Coll Surg. 2023 Apr 1;236(4):575-585. doi: 10.1097/XCS.0000000000000548. Epub 2023 Jan 10. J Am Coll Surg. 2023. PMID: 36728380

6

Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysis.

Weiser R, Polychronopoulou E, Hatch SS, Haque W, Ghani HA, He J, Kuo YF, Gradishar WJ, Klimberg VS. Weiser R, et al. Cancer. 2022 May 1;128(9):1738-1747. doi: 10.1002/cncr.34127. Epub 2022 Feb 9. Cancer. 2022. PMID: 35137951 Free article.

7

De-escalation of Endocrine Therapy in Early Hormone Receptor-positive Breast Cancer: When Is Local Treatment Enough?

Weiser R, Polychronopoulou E, Kuo YF, Haque W, Hatch SS, Tyler DS, Gradishar WJ, Klimberg VS. Weiser R, et al. Ann Surg. 2021 Oct 1;274(4):654-663. doi: 10.1097/SLA.0000000000005064. Ann Surg. 2021. PMID: 34506321

8

ASO Author Reflections: Breast Cancer: What is in a Positive Node?

Weiser R, Klimberg VS. Weiser R, et al. Ann Surg Oncol. 2021 Dec;28(13):8728. doi: 10.1245/s10434-021-10436-w. Epub 2021 Jul 13. Ann Surg Oncol. 2021. PMID: 34255247 No abstract available.

9

The significance of the pattern of serum CA125 level ascent to above the normal range in epithelial ovarian, primary peritoneal and tubal carcinoma patients.

Levy T, Weiser R, Boaz M, Ben Shem E, Golan A, Menczer J. Levy T, et al. Among authors: weiser r. Gynecol Oncol. 2013 Apr;129(1):165-8. doi: 10.1016/j.ygyno.2012.12.024. Epub 2012 Dec 27. Gynecol Oncol. 2013. PMID: 23274778

10

Reply to "The use of national datasets to evaluate outcomes for invasive lobular carcinoma".

Weiser R, Polychronopoulou E, Klimberg VS. Weiser R, et al. Cancer. 2022 Sep 15;128(18):3418-3419. doi: 10.1002/cncr.34382. Epub 2022 Jul 8. Cancer. 2022. PMID: 35801816 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page